Last updated on January 2019

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)


Brief description of study

A 12 month study to measure the efficacy and safety of abaloparatide in men with osteoporosis.

Detailed Study Description

The primary objective of this prospective controlled study is to evaluate the efficacy and the safety of abaloparatide-SC 80 mcg per day compared to placebo as assessed by change in bone mineral density over 12 months.

Clinical Study Identifier: NCT03512262

Find a site near you

Start Over

Radius Health, Inc.

Waltham, MA United States
4.33miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.